type here...

CATEGORIES

Pharmaceutics

LATEST

1...91011Page 10 of 11

TRENDING

EDITORS CHOICE

FDA Approves Drug Combination for Treating Mesothelioma

Medika Life -
First approval in 16 years for mesothelioma, a type of cancer caused by inhaling asbestos fibers SILVER SPRING, Md., Oct. 2, 2020 /PRNewswire/ -- Today, the U.S. Food...

Atorvastatin (Lipitor)

Medika Life -
Atorvastatin, sold under the brand name Lipitor, is the number one prescribed drug in America in 2021. Atorvastatin is a statin used to control

Colorado Charts Its Own Course on Vaccines Amid Federal Pullback

Medika Life -
In response to abrupt and politicized changes to federal vaccine policy, concerned Coloradans have taken several steps to shore up support for vaccine science. A bill passed...

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life -
SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories